FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis

PHASE3CompletedINTERVENTIONAL
Enrollment

375

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions
Ulcerative Colitis
Interventions
DRUG

OPC-6535 Tablets (drug)

Trial Locations (23)

12180

Upstate Gastroenterology Associates, Troy

21229

Digestive Disease Associates, Baltimore

21401

Digestive Disorders Associates, Annapolis

23502

Digestive and Liver Disease Specialists, Norfolk

27262

Bethany Medical Center, High Point

28401

Hanover Medical Specialists, P.A., Wilmington

29203

Columbia Gastroenterology Associates, Columbia

32174

Gastroenterology Consultants, P.A., Ormond Beach

33156

Lovelace Scientific Resources Florida, Miami

33162

Venture Research Institute LLC, North Miami Beach

33173

Miami Research Associates, Miami

38120

Memphis Gastroenterology Group, PC, Memphis

45219

Consultants for Clinical Research, Cincinnati

45440

Gastrointestinal and Liver Diseases Consultants, Dayton

70809

Gastroenterology Associates, LLC, Baton Rouge

73112

Sooner Clinical Reserach, Oklahoma City

77030

Digestive Associates of Houston, Houston

77090

Houston Digestive Diseases Clinic, Houston

80033

Western States Clinical Research, Inc., Wheat Ridge

85258

Ascent Clinical Research, Scottsdale

90045

West Gastroenterology Medical Group, Los Angeles

92704

Lovelace Scientific Resources, Santa Ana

Unknown

Akron Gastroenterology Associates, Inc., Akron

All Listed Sponsors
lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

NCT00064441 - FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis | Biotech Hunter | Biotech Hunter